key: cord-0267088-dvb1sk0m
authors: Macedo-da-Silva, Janaina; Rosa-Fernandes, Livia; de Moraes Gomes, Vinicius; Santiago, Verônica Feijoli; Molnár, Catarina Maria Stanischesk; Barboza, Bruno R.; de Sousa, Edmarcia Elisa; Durigon, Edison Luiz; Marinho, Claudio R. F.; Wrenger, Carsten; Marie, Suely Kazue Nagahashi; Palmisano, Giuseppe
title: Protein arginylation is regulated during SARS-CoV-2 infection
date: 2021-11-04
journal: bioRxiv
DOI: 10.1101/2021.11.02.466971
sha: 7522d2ce854173bc655911f4fa651bb5a9a06d3c
doc_id: 267088
cord_uid: dvb1sk0m

In 2019, the world witnessed the onset of an unprecedented pandemic. In September 2021, the infection by SARS-CoV-2 had already been responsible for the death of more than 4 million people worldwide. Recently, we and other groups discovered that SARS-CoV-2 infection induces ER-stress and activation of unfolded protein response (UPR) pathway. The degradation of misfolded/unfolded proteins is an essential element of proteostasis and occurs mainly in lysosomes or proteasomes. The N-terminal arginylation of proteins is characterized as an inducer of ubiquitination and proteasomal degradation by the N-end rule pathway. Here we present, for the first time, data on the role of arginylation during SARS-CoV-2 infection. We studied the modulation of protein arginylation in Vero CCL-81 and Calu-3 cells infected after 2h, 6h, 12h, 24h, and 48h. A reanalysis of in vivo and in vitro public omics data combined with immunoblotting was performed to measure the levels of ATE1 and arginylated proteins. This regulation is seen specifically during infections by coronaviruses. We demonstrate that during SARS-CoV-2 infection there is an increase in the expression of the ATE1 enzyme associated with regulated levels of specific arginylated proteins. On the other hand, infected macrophages showed no ATE1 regulation. An important finding revealed that modulation of the N-end rule pathway differs between different types of infected cells. We also confirmed the potential of tannic acid to reduce viral load, and furthermore, to modulate ATE1 levels during infection. In addition, the arginylation inhibitor merbromin (MER) is also capable of both reducing viral load and reducing ATE1 levels. Taken together, these data show the importance of arginylation during the progression of SARS-CoV-2 infection and open the door for future studies that may unravel the role of ATE1 and its inhibitors in pathogen infection.

In 2019, the world witnessed the onset of an unprecedented pandemic 1 . Patients in the capital and largest city in China's Hubei province, Wuhan, developed pneumonia associated with infection with a new type of coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 2,3 . Clinical symptoms presented by infected patients ranged from mild to severe and included nonspecific manifestations such as fever, cough, sore throat, respiratory failure, muscle damage, and death 2, 4, 5, 6 . Although there had been a great worldwide mobilization to contain the exponential spread of SARS-CoV-2, and even considered less pathogenic than other coronaviruses 7, 8 , in September 2021 the death of more than 4 million people in the world were due to the new coronavirus infection 9 (https://covid19.who.int/). The search for effective treatments and measures to fight the pandemic has driven studies that try to elucidate the infectious mechanisms of SARS-CoV-2 10 . As it belongs to the Coronaviridae family, the new coronavirus has similarities in structure and pathogenicity with SARS-CoV, both being single-stranded positive RNA viruses (+ssRNA) 11 . However, differences in the structural Spike (S) glycoprotein were identified in the SARS-CoV-2 which attributed greater efficiency in its dissemination compared to other coronaviruses 12, 13 .

During the replication cycle, SARS-CoV proteins use the host's endoplasmic reticulum (ER) to induce the formation of double-membrane vesicles for RNA synthesis, followed by the assembly of virions in the ER-Golgi intermediate compartment by structural proteins 14, 15 .

The intense use of the host's ER during viral replication increases the stress in this compartment, resulting in the accumulation of misfolded proteins and activation of the unfolded protein response (UPR) 15, 16 . Recently, we 17 and other groups discovered that SARS-CoV-2 infection also induces ER-stress and may be associated with patient survival 17, 18, 19 . The UPR pathway is highly conserved and regulates important cellular events such as growth, defense, homeostasis, and cell survival 13, 20 . In addition, this pathway activation may also boost tissue repair processes. The degradation of misfolded/unfolded proteins is an essential element of proteostasis 21 and occurs mainly in lysosomes or proteasomes, which degrade long-lived and short-lived proteins, respectively 22, 23, 24 .

Ubiquitination is a universal tagging for protein degradation and is recognized by the proteasome 25, 26 . The N-terminal arginylation of proteins is characterized as an inducer of ubiquitination and proteasomal degradation by the N-end rule pathway, as elucidated by Varshavsky et. al 27, 28 . A direct relationship between the half-life of a protein and its Nterminal residue has been demonstrated 27, 28 . While methionine promotes protein stability, other amino acids, including arginine, result in rapid degradation 27, 28 . Studies have demonstrated the arginylation of different proteins in oxidized cysteine residues or aspartic acid and glutamic acid exposed at the N-terminus 29, 30, 31, 32, 33 . N-terminal asparagine and glutamine are tertiary destabilizing residues, as they can undergo an enzymatic deamidation reaction and be converted into glutamic acid and aspartic acid, recognized as secondary sites 33 . Thus, arginylated proteins or protein fragments with tertiary and secondary residues exposed at the N-terminus are universally recognized as marked for degradation through the ubiquitination-proteasome pathway 34, 35 . Moreover, internal aspartic and glutamic acids have been found to be sites specifically arginylated on several proteins involved in different biological processes 32, 36, 37 .

Protein arginylation has been associated with cellular stress conditions 38 , including ERstress, oxidative stress, and misfolded protein stress 38, 39, 40 . Under these conditions, arginylation promotes cell death or growth arrest 40 . Furthermore, the activity of arginyl-tRNA-protein transferase (ATE1), the enzyme that promotes arginylation, is necessary to decrease mutation events when a cell is subjected to stressful conditions that damage DNA 39 .

In 2002, the knockout of the ATE1 gene resulted in abnormalities in essential processes such as cardiac development, angiogenesis, and tissue morphogenesis in mammals 41 . However, the role of arginylation in infectious diseases has been little explored and is currently unknown.

In order to increase the knowledge on this topic, we present for the first-time data on the role of arginylation during SARS-CoV-2 infection. We conducted a study on the modulation of the N-end rule pathway and protein arginylation in Vero CCL-81 and Calu-3 cells infected after 2h, 6h, 12h, 24h, and 48h. A reanalysis of public omics data combined with western blotting was performed to measure the levels of ATE1 and arginylated proteins. We demonstrated that during viral infection there was an increase in the expression of the ATE1.

Furthermore, there was a strong correlation between ATE1 levels and ER-related processes.

We also demonstrated the potential of tannic acid and merbromin (MER) to reduce viral load, and furthermore, to modulate ATE1 levels during infection.

Previously published studies were used to verify the abundance of proteins that make up the N-end rule pathway in non-infected and SARS-CoV-2 infected groups: 

The tidyverse 59 61 . The analysis of gene ontology (GO) was determined by the g:profile 62 and DAVID 63 tools. A q-value threshold of 0.05 was used, corrected by the Benjamini-Hochberg method 64 . InteractiVenn was used to build the Venn diagrams 65 . The String database v.11.5 was applied for protein network analysis (https://string-db.org/) with the following parameters: medium confidence score (0.400); textmining, co-expression, and neighborhood enabled.

Expression matrices were loaded into RStudio (v. 4.0.3) with the Seurat package 66 . A filter to remove cells with less than 200 expressed genes or more than 25% of mitochondrial transcripts was applied using the 'subset()' function in each sample. Then cell counts were log-normalized by a size factor of 10,000 RNA counts and feature selection was performed by selecting the 2,000 genes with the highest dispersion. Unsupervised identification of anchor correspondences between the canonical correlation analysis (CCA) space of each sample normalized data was performed with the 'FindIntegrationAnchors()' function with 30

dimensions. After that, the data was integrated by 'IntegrateData()' function and scaled using 'ScaleData()'. Principal component analyzes (PCA) and uniform approximation and projection dimension reduction (UMAP) with 30 principal components were applied. A nearest neighbor plot using 30 PCA reduction dimensions was calculated using 'FindNeighbors()', followed by clustering using 'FindClusters()' with a resolution of 0.5. The

Metaboanalyst platform 67 was used to evaluate differently regulated genes between cell clusters identified in the single-cell RNA-seq analysis.

Vero CCL-81 cells were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin-streptomycin, 4.5 g/L glucose, 2 mM L-glutamine, 1 mM sodium pyruvate, and 1.5 g/L NaHCO3. Calu-3 cells were cultured in DMEM medium supplemented with 20% FBS, 1% non-essential amino acids, 4.5 g/L glucose, 2 mM Lglutamine, 1 mM sodium pyruvate, 100 U/ml penicillin-streptomycin and 1.5 g/L NaHCO3. 

In this study, SARS-CoV-2 isolate HIAE-02: SARS-CoV-2/SP02/human/2020/BRA (GenBank accession number MT126808) 69 

Proteins were extracted from cellular lysates and quantified using the Qubit Protein Assay Kit platform (Invitrogen) according to the manufacturer's instructions. A total of 15µg of proteins were separated by SDS-PAGE and electrotransferred to PVDF membranes, which were directly incubated with blocking buffer (5% bovine serum albumin (BSA) in Trisbuffered saline (TBS) at 0.05% Tween-20 (TBST) for 1h. Subsequently, samples were incubated with primary antibodies ( Table 1 ) overnight and washed three times with TBST.

Then, the bands were incubated with the respective secondary antibodies for 1h at room temperature. Immunoreactive bands were detected with the ChemiDoc XRS Imaging System equipment and protein quantification was performed using the ImageJ software. Graphs were plotted using GraphPad Prism version 8.1 software. Bands with statistically significant intensities among groups were evaluated by applying an Ordinary One-way ANOVA, with

Tukey post-hoc test (0.05 cut-off). 

To explore protein arginylation during SARS-CoV-2 infection, we performed a study combining multi-omics (in silico) analysis and validated the findings mined in silico in time-course SARS-CoV-2 infection experiments at protein level by immunoblotting (Fig. 1A) .

Initially, the basal levels of enzymes involved in the N-end rule pathway were evaluated in different uninfected cells and compared to the total proteome profile (Fig. 1B) . Enzymes 42, 44, 45, 47 . To confirm the above listed findings, western blotting analysis was performed to measure ATE1 levels (Fig. 2B) . In agreement with the omics data, SARS-CoV-2 infected Calu-3 and Vero CCL-81 cells had statistically higher ATE1 levels compared to the CTRL uninfected group (Fig. 2B) . 

Once the increased abundance of ATE1 was confirmed in the infection, a multi-correlation analysis was performed using omics data to verify which proteins correlated with ATE1 (Fig.   3A) . Only differentially regulated proteins/genes were selected from six studies 42, 43, 45, 46, 47, 48 . A total of 365 proteins/genes presented a significant correlation (p-value < 0.05) with ATE1 in at least two studies and 28 in at least three studies (Supplementary File 2) .

Analyzing the molecular functions (MF) of the 28 correlated proteins/genes, the enrichment of processes related to unfolded protein binding, protein-folding chaperone, and ubiquitinprotein ligase binding were found (Fig. 3B) . Among the biological processes (BP), events related to ER and viral infection were enriched, such as protein target to ER, protein localization to ER, viral gene expression, and viral transcription (Fig. 3C) . Pathways related to alterations in processes linked to RNA and coronavirus infection were also enriched (Fig.   3D ). The GBP2 protein, involved in cellular response to infections, was correlated with ATE1 in four studies. Due to the observed relationship between the processes linked to the ER ( Fig. 3B and C) , we monitored the direction of the correlation of HSPBP1 (Fig. 3E) and HSP90B1 ( Fig. 3F) with ATE1. These proteins showed significant positive correlations, except for the negative correlation observed in lung tissue by Qiu et al 45 .

After identifying a relationship between ATE1 and ER-associated chaperones/processes during SARS-CoV-2 infection, the arginylation levels of proteins located in the ER, heat shock protein family A (Hsp70) member 5 (HSPA5, also known as BIP), calreticulin (CALR), and protein disulfide isomerase (PDI) were analyzed by western blotting (Fig. 4) .

The BIP/HSPA5 arginylated protein level increased in both cell models over time with statistical significance 48h after the onset of infection (Fig. 4A) . Interestingly, the arginylated CALR protein level decreased in Vero CCL-81 cells while increased in Calu-3 cells (Fig.   4B ) compared to the CTRL uninfected cells. The PDI protein showed a significant decrease 6h after the start of infection in Calu-3 cells and is statistically more arginylated in Vero CCL-81 cells infected after 48h (Fig. 4C) . Fig. 5B and C) . The subcellular location of the 152 arginylated proteins were mainly in the cytoskeleton, cytoplasm, and nucleus (Fig. 5D) . Since the ACTB protein was previously identified as arginylated by Seo et al 56 (

CCL-81 at 2, 6, 12, 24, 48h after infection.

In view of the close relationship between arginylation and SARS-CoV-2 infection demonstrated by the previous data, an enzyme inhibition assays by 1µM tannic acid and 25µM merbromin (MER) in Calu-3 cells were performed (Fig. 6) . These concentrations of MER and tannic acid did not affect cellular viability. Notably, the infected cells before any treatment (INF-24h) presented higher expression of ATE1 than uninfected cells (CTRL), and the treatment with tannic acid and MER decreased significantly the ATE1 expression at 24 and 72h, respectively, to the level observed in uninfected (CTRL) cells. Interestingly, the expression level of the cytoskeleton protein, ACTB, also decreased after to the treatment with ATE1 inhibitors, corroborating the findings that the increased expression of ACTB after 24h after infection was associated to ATE1 activity (Fig. 5E ). In addition, tannic acid inhibited arginylation in earlier time point (24h) compared to MER (72h). The ER proteins (CALR and PDI) expression levels decreased similarly to ATE1 and ACTB, however less pronounced, due to reduced arginylation after exposure to inhibitors. Interestingly, the BiP/HSP5A protein expression pattern differed from the other proteins (Fig. 6) . There was an increase in the abundance of arginylated protein in relation to the CTRL group, which corroborated that the abundance of ATE1 was possibly not only related to the reduction in the levels of arginylation of the BiP/HSPA5 (Fig. 4A) . Of note, tannic acid and MER were able to reduce the viral load or prevent virus entry into the cell. Such effect was more relevant in the inhibition with MER (Fig. 6C) . 

After verifying the expression and subcellular location of proteins involved in the arginylation process, we investigated which cell types express ATE1. A reanalysis of singlecell RNASeq data published by Chua et. al 58 was conducted using INF group consisted by critically ill patients, hospitalized for more than 20 days or who died due to the progression of COVID-19, and CTRL group of not infected with the virus using nasopharyngeal/pharyngeal swabs samples. A total of 17 cell clusters were identified (Fig.   7A ). Observing the representativeness of each patient in the cell clusters, it was possible to verify that clusters 4, 7, and 8 presented a statistical difference (p < 0.05) between the INF and CTRL groups (Fig. 7B) . We identified clusters 4, 9, 15, and 17 as clusters expressing ATE1 (Fig. S2A) . (Fig. S2) . The macrophages present in cluster 4

were isolated and the genes differentially regulated between the CTRL and INF groups were determined (Fig. S2B) . The expressions of ATE1, CALR, ACTB, PDIA3, PDIA6, and PDIA4

genes did not show statistical significance between the groups (Fig. S2C) . However, the BiP/HSPA5 gene expression was increased in the INF group. The upregulated genes in cluster 4 were associated with interferon type I induction and signaling during SARS-CoV-2 infection, pulmonary fibrosis, proteasome degradation, and ferroptosis. On the other hand, the downregulated genes were related to peptide chain elongation, oxidative phosphorylation, and MHC class II complex (Fig. S3) . To verify the modulation of arginylation, a western blotting was performed in macrophages infected with SARS-CoV-2 (Fig. 7C) . We confirmed that there was no difference in the ATE1 modulation between the CTRL and INF groups after 24h and 48h of infection. In addition, the inhibitors induced an increase in ATE1 enzyme levels in macrophages at 48h (MER) and 24h (tannic acid) after treatment. The abilities of tannic acid to decrease arginylation levels occurred mainly after 48h of infection (Fig. 7C) . These data suggested that the arginylation behavior in infected macrophages was different from that observed in Vero CCL-81 and Calu-3 cells. The expressions of ER chaperones, CALR and BIP, and ACTB showed statistical significance between the INF (48h) and CTRL groups in western blotting assays (Fig. 7C) , with reduced expressions in clusters 9, 15, and 17 (Fig. S4) , we identified a statistically significant increase of ATE1 in the INF group in cluster 15, which was enriched mainly with epithelial cell markers (Supplementary File 4) . (C) Representative images of western blotting analysis of infected macrophages, indicating the modulation of ATE1 and arginylated and total CALR, PDI, BiP, and ACTB proteins.

We verified whether modulation of the N-end rule pathway was recurrent in other respiratory viral infections or it was a specific signature of SARS-CoV-2 (Fig. S5) 

In this study, we confirmed the modulation of the N-end rule pathway and proteins arginylation during SARS-CoV-2 infection by a combined in silico analysis of multi-omic studies and orthogonal experimental validation (Fig.1) . We demonstrated, for the first time, an increase of ATE1expression, a critical enzyme involved in arginylation, during in vitro SARS-CoV-2 infection (Fig.2) . In fact, in human Calu-3 cells, a progressive increase of ATE1 expression was observed after 6h of SARS-CoV-2 infection, when an increase of viral proteins has been previously demonstrated 46 . Interestingly, increased ATE1 expression was also observed in a monkey-derived cell line (Vero E6) indicating that this modulation may occur independent to species. Moreover, ATE1 expression increase was also demonstrated in MERS-CoV (24h) and SARS-CoV (36h) infections 51 , but not in other respiratory viruses infections such as RSV 75, 54, 76 and influenza 49, 50 , suggesting that involvement of the N-end rule pathway may be a molecular signature specific for the Coronaviridae family.

A previous study by our group revealed an activation of the UPR pathway after 6h of SARS-CoV-2 infection 17 , corroborating previous observation of ER-stress enhancement 26 and UPR pathway activation during viral infection 18, 19 . Based on these findings, we hypothesized that increased misfolded or unfolded proteins produced during SARS-CoV-2 infection may be tagged for degradation by arginylation in order to maintain cellular homeostasis. In fact, our in silico multiomic analysis identified several ER-related proteins associated with ATE1 expression (Fig.3) , including BiP/HSPA5, PDI and CALR, and we followed their arginylation rate along with the infection (Fig.4) . protein is a redox-regulated chaperone related to the formation, isomerization, and reduction of disulfide bonds 83 . Our multi-omic analysis identified the downregulation of PDI members and immunoblot data points to a significant reduction in PDI levels 6h after infection, suggesting that the interaction between viral S-glycoprotein and ACE2 is not being affected by the dependent redox status of PDI. The UPR pathway is activated to restore ER homeostasis, and in case of failure, apoptotic events are induced 84 . The virus can also hijack the host's ubiquitination machinery 85 ; however, the biological functions of this action are still unknown.

Our multi-omic analysis demonstrated that the arginylation-related proteins were mainly located in the ER, convergent to our in vitro results of the proteins involved in the UPR pathway. Additionally, the arginylation-related proteins were also located in the cytoskeleton, a key structure in the host-pathogen interaction 86 (Fig. 5) . Cytoskeleton proteins participate throughout the viral replication cycle, as SARS-CoV-2 enters into target cells using intermediate filament proteins, sequesters microtubules to transport itself to replication/assembly sites, and promotes polymerization of actin filaments to exit the cell 87, 88 . Moreover, cytoskeleton proteins were among the experimentally arginylated proteins identified in previous studies (Seo et al. 56 and Wong et al. 57 ). We monitored the arginylation levels of one major cytoskeleton protein, ACTB, and we observed its increase in the first 2h

after infection in Calu-3 cells, with a decrease at 48h, when apoptosis-related proteins were activated 17 . The ACTB arginylation pattern was different in infected Vero cells, as was already observed for phosphorylation 89 90 . We also demonstrated ATE1 protein expression in macrophages. However, no difference in the abundance of proteins related to arginylation was detected comparing CTRL and INF groups (Fig 7) . In fact, previous study has shown that SARS-CoV-2 was capable of infecting macrophages without causing any cytopathic effect, and the virus was also capable of inducing host immunoparalysis 91 . Moreover, we also identified a cellular compartment with epithelial cell markers presenting significant increase of ATE1 expression, consistent with previous observation of ATE1 protein expression in the main lung epithelial cells, ciliary cells type 1 and 2, infected by SARS-CoV-2 92 . ATE1 expression in lung epithelial cells was higher in SARS-CoV-2 infected patients compared to controls.

Notably, we found that arginylation inhibitors, tannic acid and MER decreased viral load or prevented viral entry into the cell. Furthermore, our assays indicated a decrease in the abundance of ATE1 (Fig.6) . Tannic acid was recently described as a potent inhibitor of SARS-CoV-2, through the thermodynamically stable binding with the proteins Mpro and TMPRSS2, crucial for the entry of the virus into the cell 93 . Here, we confirmed the potential of tannic acid to reduce viral load, and furthermore, to modulate ATE1 levels during

infection. In addition, we also demonstrated for the first time that, like tannic acid, the arginylation inhibitor MER was also capable of reducing both viral load and ATE1 level.

Our main findings are summarized in Fig. 8 .

We 

COVID-19 pandemic: A review based on current evidence

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

First Case of 2019 Novel Coronavirus in the United States

Mild or Moderate Covid-19

A comprehensive review of COVID-19 characteristics

Clinical Symptom Differences Between Mild and Severe

SARS-CoV-2 and COVID-19: The most important research questions

COVID-19, SARS and MERS: are they closely related?

Prediction of the confirmed cases and deaths of global COVID-19 using artificial intelligence

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis

SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview

Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2

Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein

Coronavirus-induced ER stress response and its involvement in regulation of coronavirus-host interactions

Endoplasmic Reticulum Stress Markers in SARS-COV-2 Infection and Pneumonia: Case-Control Study

SARS-CoV-2 activates ER stress and Unfolded protein response

The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta

Modulation of SARS-CoV-2 Spike-induced Unfolded Protein Response (UPR) in HEK293T cells by selected small chemical molecules

Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy

Unfolded Protein Response in Acute Respiratory Distress Syndrome

Proteostasis: a new therapeutic paradigm for pulmonary disease

Protein degradation by the ubiquitinproteasome pathway in normal and disease states

Proteasomal and lysosomal protein degradation and heart disease

Diversity of degradation signals in the ubiquitinproteasome system

Monoubiquitination joins polyubiquitination as an esteemed proteasomal targeting signal

The N-end rule pathway

The N-end rule pathway and regulation by proteolysis

Post-translational arginylation of ornithine decarboxylase from rat hepatocytes

A novel form of neurotensin post-translationally modified by arginylation

Enzymatic arginylation of beta-melanocyte-stimulating hormone and of angiotensin II

Protein arginylation targets alpha synuclein, facilitates normal brain health, and prevents neurodegeneration

The N-end rule pathway is a sensor of heme

Amino-terminal arginylation as a degradation signal for selective autophagy

N-degron and C-degron pathways of protein degradation

Arginyltransferase ATE1 catalyzes midchain arginylation of proteins at side chain carboxylates in vivo

Target site specificity and in vivo complexity of the mammalian arginylome

Arginylation: a new regulator of mRNA stability and heat stress response

Posttranslational arginylation enzyme Ate1 affects DNA mutagenesis by regulating stress response

Protein arginylation regulates cellular stress response by stabilizing HSP70 and HSP40 transcripts

Posttranslational arginylation as a global biological regulator

Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2. iScience

Multi-organ proteomic landscape of COVID-19 autopsies

Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples

Postmortem Tissue Proteomics Reveals the Pathogenesis of Multiorgan Injuries of COVID-19

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Transcriptional and proteomic insights into the host response in fatal COVID-19 cases

Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection

RNA-Seq transcriptome data of human cells infected with influenza A/Puerto Rico/8/1934 (H1N1) virus

Transcriptome Profiling Reveals Differential Effect of Interleukin-17A Upon Influenza Virus Infection in Human Cells

Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing

Time-course of transcriptome response to respiratory syncytial virus infection in lung epithelium cells

Transcriptome of airway neutrophils reveals an interferon response in life-threatening respiratory syncytial virus infection

A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection

Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing

R-catcher, a potent molecular tool to unveil the arginylome

Global analysis of posttranslational protein arginylation

COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis

Welcome to the Tidyverse

SeqinR 1.0-2: A Contributed Package to the R Project for Statistical Computing Devoted to Biological Sequences Retrieval and Analysis

A Bioconductor workflow for processing and analysing spatial proteomics data

Profiler--a web-based toolset for functional profiling of gene lists from large-scale experiments

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)

InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams

Comprehensive Integration of Single-Cell Data

MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights

PMA-Induced THP-1 Macrophage Differentiation is Not Impaired by Citrate-Coated Platinum Nanoparticles

SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles

CD163: a specific marker of macrophages in paraffin-embedded tissue samples

The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia

Triggering MSR1 promotes JNK-mediated inflammation in IL-4-activated macrophages

Differential proteomic analysis of children infected with respiratory syncytial virus

Immune profiles provide insights into respiratory syncytial virus disease severity in young children

The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19

Amino-terminal arginylation targets endoplasmic reticulum chaperone BiP for autophagy through p62 binding

Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase

Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants

Contrasting functions of calreticulin and calnexin in glycoprotein folding and ER quality control

Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor

Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection

Insights Into the Role of Endoplasmic Reticulum Stress in Infectious Diseases

Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response

Pathogens and polymers: microbe-host interactions illuminate the cytoskeleton

Cytoskeleton-a crucial key in host cell for coronavirus infection

Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System

Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis

Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19

Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease

Supplementary File 1. N-end rule pathway (Zecha et

Potential to be arginylated (Human proteome) (B); Potential to be arginylated (Zecha et

Differentially regulated proteins (Saccon et. al) (D); Differentially regulated proteins

E)

Differentially regulated proteins (Leng et. al) (F)

Differentially regulated proteins (Qiu et. al) (G)

Differentially regulated proteins (Bojkova et. al) (H); Differently regulated transcripts (Wu et. al) (I) and Differentially regulated transcripts (Desai et. al) (J)

Supplementary File 2. Proteins and genes correlated with ATE1 in Saccon et. al (A)

Venn diagram of correlated proteins (G)

and Gene ontology analysis of correlated proteins (H)

Supplementary File 3. Subcellular location of proteins correlated with ATE1 (At least 2 studies) (A)

Subcellular location of proteins correlated with ATE1 (At least 3 studies) (B)

Differentially regulated arginylated proteins (experimentally validated) (C) and List of 152 arginylated proteins experimentally validated

All markers for each clusters (A); matrix expression for: cluster 4

G); cluster 15 (H); and cluster 17 (I); Cell markers for: cluster 9

Gene ontology analysis of upregulated (M) and downregulated (N) genes in cluster 4

The authors declare no competing interests.